ABN Amro Investment Solutions Grows Stake in Intuitive Surgical, Inc. $ISRG

ABN Amro Investment Solutions lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.2% during the 1st quarter, Holdings Channel.com reports. The fund owned 30,250 shares of the medical equipment provider’s stock after buying an additional 5,094 shares during the period. ABN Amro Investment Solutions’ holdings in Intuitive Surgical were worth $13,945,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. boosted its stake in Intuitive Surgical by 3.9% in the first quarter. PNC Financial Services Group Inc. now owns 166,908 shares of the medical equipment provider’s stock valued at $76,943,000 after acquiring an additional 6,231 shares in the last quarter. Oslo Pensjonsforsikring AS acquired a new stake in shares of Intuitive Surgical during the first quarter worth about $300,000. Andra AP fonden lifted its holdings in shares of Intuitive Surgical by 139.7% in the 1st quarter. Andra AP fonden now owns 50,050 shares of the medical equipment provider’s stock valued at $23,073,000 after purchasing an additional 29,168 shares during the last quarter. Wilkerson Advisory Group LLC lifted its holdings in shares of Intuitive Surgical by 1,117.1% in the 1st quarter. Wilkerson Advisory Group LLC now owns 426 shares of the medical equipment provider’s stock valued at $196,000 after purchasing an additional 391 shares during the last quarter. Finally, Glenview Trust Co boosted its position in shares of Intuitive Surgical by 5.6% in the 1st quarter. Glenview Trust Co now owns 123,234 shares of the medical equipment provider’s stock valued at $56,810,000 after purchasing an additional 6,572 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.9%

Shares of ISRG stock opened at $350.06 on Wednesday. The business’s 50 day moving average is $412.30 and its two-hundred day moving average is $464.06. Intuitive Surgical, Inc. has a twelve month low of $342.10 and a twelve month high of $603.88. The company has a market capitalization of $123.98 billion, a P/E ratio of 40.10, a price-to-earnings-growth ratio of 2.72 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 17.09% and a net margin of 28.45%.The business had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $2.83 billion. During the same quarter in the prior year, the business earned $1.81 earnings per share. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 8.61 earnings per share for the current fiscal year.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Recent commentary highlights that Intuitive Surgical’s latest earnings were impressive, with the company continuing to post strong growth and beating expectations, which supports the long-term investment case. Article Title
• Positive Sentiment: Analysts and recent coverage argue the stock may be oversold, with Wall Street estimate revisions moving higher and some writers saying the pullback could create a buying opportunity for growth investors. Article Title
• Positive Sentiment: One valuation-focused piece says ISRG is being priced for slower growth than it is currently delivering, suggesting the stock could be undervalued if the company maintains its current pace. Article Title
• Neutral Sentiment: Multiple articles note that ISRG has become a heavily watched and widely discussed stock, reflecting heightened investor attention rather than a clear new business catalyst. Article Title
• Negative Sentiment: Despite the strong fundamentals, the stock has fallen sharply over the past several weeks, and several reports frame the decline as a correction driven by investor caution around valuation and recent price weakness. Article Title

Insider Activity at Intuitive Surgical

In other news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the sale, the executive vice president directly owned 5,720 shares in the company, valued at approximately $2,426,080.80. The trade was a 6.54% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 7,169 shares of company stock worth $3,059,135 in the last three months. Insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on ISRG shares. Evercore set a $430.00 price target on Intuitive Surgical in a research note on Monday, July 6th. Stifel Nicolaus decreased their price objective on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a report on Friday, July 17th. BTIG Research lowered their target price on shares of Intuitive Surgical from $512.00 to $469.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. Sanford C. Bernstein cut their target price on shares of Intuitive Surgical from $750.00 to $685.00 and set an “outperform” rating on the stock in a report on Friday, July 17th. Finally, Robert W. Baird decreased their price target on shares of Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, July 17th. Twenty-one analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $523.46.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.